Switzerland has long functioned as a crossroads for international deal-making. It is not part of the European Union, yet it is woven into European supply chains. It offers a stable currency, a predictable legal system, and a network of tax treaties that have attracted capital for decades. For buyers and sellers, the country presents a familiar paradox: access without membership, opportunity without full regulatory alignment.
Inbound mergers and acquisitions have historically clustered in pharmaceuticals, banking, luxury goods, and commodities trading. Swiss giants like Novartis, Roche, and Nestlé have been active acquirers abroad, while foreign private equity firms have targeted Swiss mid-market companies for their engineering expertise and reliable cash flows. But the landscape has changed. The Swiss government’s introduction of foreign investment screening in 2023 gave authorities the power to block acquisitions in sensitive sectors, adding a layer of national security review that did not exist before.
Prospero Pica, chief executive of Prospero, notes that this has altered how cross-border deals are planned. “Switzerland was once treated as a frictionless entry point. Buyers assumed that if the deal made financial sense, it would clear. Now there is a distinct screening process. It is not prohibitive, but it requires earlier engagement with regulators and a credible narrative about why the transaction benefits Swiss economic interests. Deals are still happening, but the timeline has shifted.”
The regulatory structure itself is fragmented. The Swiss Competition Commission reviews mergers for anti-competitive effects, while sector-specific bodies like FINMA and the Federal Office of Public Health maintain separate oversight. This multi-channel approach can extend approval timelines compared to EU jurisdictions where a single authority handles competition review. Switzerland’s bilateral agreements with Brussels also stop short of corporate law harmonization, leaving buyers to navigate diverging accounting standards, labor rules, and data-protection regimes.
Currency risk remains a persistent complication. The Swiss franc appreciates during global uncertainty, making Swiss targets more expensive for buyers holding euros or dollars. Since the 2015 removal of the EUR/CHF currency floor, deal structures have adapted more earn-outs denominated in francs, more hedging, more creative pricing mechanisms to bridge valuation gaps.
Tax strategy, once a primary reason to route deals through Switzerland, has also evolved. Cantonal tax competition historically encouraged holding-company structures, but OECD global tax reforms and new substance requirements have narrowed those advantages. Swiss acquisition vehicles now need to demonstrate genuine operational presence rather than functioning as mailbox entities.
According to Pica, the human element is often underestimated. “Swiss M&A is relationship driven. A transaction that closes in twelve weeks elsewhere might take twenty here, not because of bureaucracy, but because trust is built through repeated contact. The multilingual environment adds another layer German, French, and Italian are all national languages, so even domestic deals can cross cultural boundaries before the international component begins.”
As geopolitical fragmentation increases, Switzerland’s role as a neutral deal-making hub faces new tests. Its ability to attract capital while satisfying national-security concerns will determine whether it remains a preferred jurisdiction or becomes a more cautious, regulated environment. For now, it occupies a middle ground: open but no longer assumed.
